We are live on ! Find out more
FFVM

Founders Fund V Management Portfolio holdings

AUM $2.16M
1-Year Est. Return 77.37%
This Fund
S&P 500
This Quarter Est. Return
+3.63%
1 Year Est. Return
+77.37%
3 Year Est. Return
+859.57%
5 Year Est. Return
-74.2%
10 Year Est. Return
AUM
$1.09M
AUM Growth
+$147K
Cap. Flow
+$18.6M
Cap. Flow %
1,703.28%
Top 10 Hldgs %
100%
Holding
4
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NVMI
Nova
NVMI
+$18.6M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 68.5%
2 Technology 31.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTH
1
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$668K 61.13%
480,708
NVMI
2
Nova
NVMI
$14.1B
$209K 19.09%
+117,924
New +$18.6M
RGTI icon
3
Rigetti Computing
RGTI
$4.88B
$136K 12.4%
88,621
UBX
4
DELISTED
Unity Biotechnology
UBX
$80.6K 7.38%
49,172

Similar funds

Founders Fund V Management's Q1 2024 Portfolio in Review

As of Q1 2024, Founders Fund V Management held 4 positions worth $1.09M, up 15% from $947K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Founders Fund V Management deployed $18.6M of net new capital in Q1 2024, opening 1 new position. Its largest new stake was Nova: 117,924 shares worth $209K.

By sector, the portfolio is most concentrated in Healthcare at 69% of assets, down from 91% a quarter earlier, followed by Technology.

  • Founders Fund V Management's largest Q1 2024 buy was Nova: 117,924 shares worth $209K.
  • Founders Fund V Management's ten largest holdings make up 100% of its $1.09M portfolio in Q1 2024.
  • Founders Fund V Management opened 1 new position and closed 0 in Q1 2024.
  • Founders Fund V Management's portfolio value rose 15% quarter-over-quarter to $1.09M.

Based on Founders Fund V Management's 13F filing for Q1 2024, filed 15 May 2024.